Abstract Viral infections can accelerate chronic liver disease (CLD) progression, yet whether SARS-CoV-2 infection drives worse long-term hepatic outcomes in patients with pre-existing CLD remains unknown. This retrospective cohort study investigated whether SARS-CoV-2 infection was associated with mortality, hepatic decompensation, and abnormal fibrosis-related laboratory markers in patients with pre-existing CLD up to 4.5 years post-infection.
Roham Hadidchi
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Roham
Contact Roham, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack